Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Pneumologie (Stuttgart, Germany)|January 25, 2021
[Investigation of the Filter Performance in a Sample of Standardised Particle-filtering Half Masks]D Dellweg, R Quast, P Haidl
Frontiers in Endocrinology|April 15, 2021
Cardiovascular Safety and Benefits of Semaglutide in Patients With Type 2 Diabetes: Findings From SUSTAIN 6 and PIONEER 6Michael A Nauck, Daniel R Quast
Klinische Monatsblatter Fur Augenheilkunde|November 11, 2011
[Experience in contrast vision testing]H Wilhelm, D Hofmann, S Roelcke, et al.
Diabetes, Obesity & Metabolism|January 26, 2023
Meta-analysis of head-to-head clinical trials comparing incretin-based glucose-lowering medications and basal insulin: An update including recently developed glucagon-like peptide-1 (GLP-1) receptor agonists and the glucose-dependent insulinotropic polypeptide/GLP-1 receptor co-agonist tirzepatideMichael A Nauck, Abd El Aziz Mirna, Daniel R Quast
Molecular Metabolism|October 17, 2020
GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-artMichael A Nauck, Daniel R Quast, Jakob Wefers, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 20, 2017
A case series of verrucae vulgares mimicking hyperkeratosis in individuals with diabetic foot ulcersD R Quast, M A Nauck, F G Bechara, et al.
Diabetes, Obesity & Metabolism|July 26, 2021
The evolving story of incretins (GIP and GLP-1) in metabolic and cardiovascular disease: A pathophysiological updateMichael A Nauck, Daniel R Quast, Jakob Wefers, et al.
Frontiers in Cardiovascular Medicine|January 30, 2023
Rate of atrial fibrillation and flutter induced tachycardiomyopathy in a cohort of hospitalized patients with heart failure and detection of indicators for improved diagnosisLynn Ermert, Fabienne Kreimer, Daniel R Quast, et al.
Klinische Monatsblatter Fur Augenheilkunde|November 6, 2013
[Assessment of mesopic and contrast vision for driving licences: which cut-off values, which methods are appropriate?]H Wilhelm, T Peters, W Durst, et al.
Oncology Research and Treatment|November 1, 2021
Low Serological Prevalence of SARS-CoV-2 Antibodies in Cancer Patients at a German University Oncology CenterOliver Overheu, Daniel R Quast, Wolfgang E Schmidt, et al.
Pageof 3